# Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France

> **NCT00842855** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 275 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00842855
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 275 (ESTIMATED)
- **Last updated:** 2011-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842855, "Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00842855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*